Moderna has received marketing authorisation from the European Commission for its updated COVID-19 vaccine, Spikevax, which ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The company last reported total revenues of $108M in Q1, down 35.3% Y/Y due to lower net product sales, particularly its ...

Moderna (MRNA) stock in focus as the company plans to cut 10% of its workforce by 2025 amid cost-saving efforts. Read more ...

The FDA greenlit multiple new drugs this month and issued some notable label expansions including for Eli Lilly’s Kisunla.

A review and meta-analysis finds shorter antibiotic courses show similar efficacy for bloodstream infections in ...

An outbreak of Legionnaires' disease in areas of Central Harlem has sickened at least 22 people, the New York City Health ...